Application Nr Approved Date Route Status External Links
ANDA202438 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications & Usage Famciclovir Tablet, A Prodrug Of Penciclovir, Is A Nucleoside Analog Dna Polymerase Inhibitor Indicated For: Immunocompetent Adult Patients ( 1.1 ) • Herpes Labialis (Cold Sores) O Treatment Of Recurrent Episodes • Genital Herpes O Treatment Of Recurrent Episodes O Suppressive Therapy Of Recurrent Episodes Hiv-Infected Adult Patients ( 1.2 ) • Treatment Of Recurrent Episodes Of Orolabial Or Genital Herpes Limitation Of Use ( 1.3 ) The Efficacy And Safety Of Famciclovir Tablets Have Not Been Established For: • Patients <18 Years Of Age • Immunocompromised Patients Other Than For The Treatment Of Recurrent Episodes Of Orolabial Or Genital Herpes In Hiv-Infected Patients • Black And African American Patients With Recurrent Genital Herpes 1.1 Immunocompetent Adult Patients Herpes Labialis (Cold Sores): Famciclovir Tablets Are Indicated For The Treatment Of Recurrent Herpes Labialis. Genital Herpes: Recurrent Episodes: Famciclovir Tablets Are Indicated For The Treatment Of Recurrent Episodes Of Genital Herpes. The Efficacy Of Famciclovir Tablets When Initiated More Than 6 Hours After Onset Of Symptoms Or Lesions Has Not Been Established. Suppressive Therapy: Famciclovir Tablets Are Indicated For Chronic Suppressive Therapy Of Recurrent Episodes Of Genital Herpes. The Efficacy And Safety Of Famciclovir Tablets For The Suppression Of Recurrent Genital Herpes Beyond 1 Year Have Not Been Established. 1.2 Hiv-Infected Adult Patients Recurrent Orolabial Or Genital Herpes: Famciclovir Tablets Are Indicated For The Treatment Of Recurrent Episodes Of Orolabial Or Genital Herpes In Hiv-Infected Adults. The Efficacy Of Famciclovir Tablets When Initiated More Than 48 Hours After Onset Of Symptoms Or Lesions Has Not Been Established. 1.3 Limitation Of Use The Efficacy And Safety Of Famciclovir Tablets Have Not Been Established For: • Patients <18 Years Of Age • Patients With First Episode Of Genital Herpes • Immunocompromised Patients Other Than For The Treatment Of Recurrent Orolabial Or Genital Herpes In Hiv-Infected Patients • Black And African American Patients With Recurrent Genital Herpes

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Famciclovir FAMCICLOVIR ZINC1530635

Comments